Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for posttraumatic stress disorder (PTSD). For more information, please visit www.recoverystudy.com or www.clinicaltrials.gov (NCT03841773).

SEC Filings
: All SEC Filings

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
07/15/19 S-1/A General form of registration statement for all companies including face-amount certificate companies
Related Documents
83
07/11/19 CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission. 1
07/11/19 S-1/A General form of registration statement for all companies including face-amount certificate companies
Related Documents
44
07/09/19 CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission. 1
07/09/19 CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission. 2
07/03/19 FWP Filing under Securities Act Rules 163/433 of free writing prospectuses 31
07/01/19 S-1/A General form of registration statement for all companies including face-amount certificate companies
Related Documents
49
06/24/19 UPLOAD SEC-generated letter
Related Documents
1
06/19/19 S-1 General form of registration statement for all companies including face-amount certificate companies
Related Documents
49
06/14/19 S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Related Documents
14